View Author
women screening cancer testing hrhpv cytology lesion study group result papillomaviru colposcopy cin grade 2 month grade hpv dna testing number vaccine netherland follow-up hpv testing cytological round vaccination methylation trial treatment infection control group detection baseline meijer cj prophylactic table vu university hrhpv testing cin 3+ lesions post-treatment rozendaal l meijer smear university cohort control prophylactic hpv vaccination disease snijders pj sensitivity cin grade 3 intervention group snijder colposcopic prophylactic vaccination hpv 16 5- year risk pathology strategy cytological testing analysis effect cytology triage cin 3+ cancer screening triage sample cervix center department self-sampling van kemenade fj 24 months parameter dsi colposcope dyskaryosi intervention referral papillomavirus testing cin 2+ signi speci ficity
10 Most Recent Publications
|
HrHPV-testing in a university hospital gynecology outpatient clinic: Recommendations for clinical practice
(Article)
Louwers, J.A. Berkhof, J. Zaal, A. Kocken, M. Rozendaal, L. Heideman, D.A.M. Baal, W.M. van Snijders, P.J.F. Verheijen, R.H.M. Meijer, C.J.L.M. |
2012-03-01
|
|
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study
(Article)
Kocken, M. Helmerhorst, T.J.M. Meijer, C.J.L.M. Berkhof, J. Louwers, J.A. Nobbenhuis, M.A.E. Bais, A.G. Hogewoning, C.J.A. Zaal, A. Verheijen, R.H.M. Snijders, P.J.F. |
2011-05-01
|
|
Dynamic spectral imaging colposcopy: Higher sensitivity for detection of premalignant cervical lesions
(Article)
Louwers, J.A. Zaal, A. Meijer, C.J.L.M. Kemenade. F.J. van Verheijen, R.H.M. Kocken, M. Harmsel, W.A. ter Graziosi, G.C.M. Spruijt, J.W.M. Berkhof, J. Balas, C. Papagiannakis, E. Snijders, P.J.F. |
2011-02-01
|
|
The health and economic effects of HPV DNA screening in the Netherlands
(Article)
Berkhof, J. Coupé, V.M. Bogaards, J.A. Kemenade, F. van Helmerhorst, T.J.M. Snijders, P.J.F. Meijer, C.J. |
2010-11-01
|
|
Colposcopic characteristics of high-risk human papillomavirus-related cervical lesions
(Article)
Louwers, J.A. Kocken, M. Bijl, J.C. van der Berkhof, J. Snijders, P.J.F. Meijer, C.J.L.M. Verheijen, R.H.M. |
2010-01-01
|
|
Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC
(Article)
Overmeer, R.M. Henken, F.E. Meijer, C.J.L.M. Steenbergen, R.D.M. Snijders, P.J.F. Claassen-Kramer, D. Berkhof, J. Helmerhorst, T.J.M. Heideman, D.A.M. Wilting, S.M. Murakami, Y. Ito, A. |
2008-08-01
|
|
Vaccination against HPV: Indications for women and the impact on the cervical screening programme
(Article)
Heideman, D.A.M. Snijders, P.J.F. Berkhof, J. Verheijen, R.H.M. Helmerhorst, T.J.M. Meijer, C.J.L.M. |
2008-07-01
|
|
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
(Article)
Bulkmans, N. Berkhof, J. Ruitinga, W. Ballegooijen, M. van Snijders, P.J.F. Meijer, C.J.L.M. Rozendaal, L. Kemenade, F. van Boeke, A. Bulk, S. Voorhorst, F. Verheijen, R. Groningen, K. van Boon, M. |
2007-11-24
|
|
Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
(Article)
Bais, A.G. Kemenade, F. van Berkhof, J. Verheijen, R.H.M. Snijders, P.J.F. Voorhorst, F. Babović, M. Ballegooijen, M. van Helmerhorst, T.J.M. Meijer, C.J.L.M. |
2007-04-01
|
|
HPV16 and increased risk of recurrence after treatment for CIN
(Article)
Gök, M. Coupé, V.M.H. Berkhof, J. Verheijen, R.H.M. Helmerhorst, T.J.M. Hogewoning, C.J.A. Snijders, P.J.F. Meijer, C.J.L.M. |
2007-02-01
|